IRIS
BOVIS, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.019
AS - Asia 2.126
NA - Nord America 1.446
SA - Sud America 179
AF - Africa 45
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.823
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.669
US - Stati Uniti d'America 1.350
SG - Singapore 869
CN - Cina 525
VN - Vietnam 333
BD - Bangladesh 146
FR - Francia 144
BR - Brasile 114
HK - Hong Kong 88
CA - Canada 47
DE - Germania 41
FI - Finlandia 40
GB - Regno Unito 40
IQ - Iraq 23
MX - Messico 23
AR - Argentina 22
IN - India 20
JP - Giappone 19
EC - Ecuador 17
ID - Indonesia 16
NL - Olanda 15
CH - Svizzera 11
TR - Turchia 11
ZA - Sudafrica 11
JM - Giamaica 10
SA - Arabia Saudita 10
ES - Italia 9
PH - Filippine 9
PK - Pakistan 9
CO - Colombia 8
KE - Kenya 8
RU - Federazione Russa 8
DZ - Algeria 7
MA - Marocco 7
AU - Australia 6
CL - Cile 6
SE - Svezia 6
TH - Thailandia 6
CR - Costa Rica 5
MY - Malesia 5
IE - Irlanda 4
JO - Giordania 4
PT - Portogallo 4
PY - Paraguay 4
TW - Taiwan 4
UA - Ucraina 4
UZ - Uzbekistan 4
GR - Grecia 3
NP - Nepal 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
PL - Polonia 2
QA - Qatar 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 19.822
Salva come PNG Salva come JPEG
Città #
Genova 7.940
Genoa 4.679
Vado Ligure 1.472
Rapallo 1.376
Singapore 408
San Jose 373
Ashburn 198
Council Bluffs 144
Lauterbourg 127
Ho Chi Minh City 106
Beijing 96
Hanoi 89
New York 87
Hong Kong 84
Bordighera 40
Santa Clara 35
Helsinki 32
Frankfurt am Main 30
Los Angeles 23
Tianjin 21
Tokyo 17
Da Nang 16
Haiphong 16
Boardman 15
Mexico City 15
São Paulo 15
Chicago 14
Rome 14
Toronto 14
Buffalo 13
Milan 13
St Louis 10
Baghdad 9
Hải Dương 9
Naples 9
Amsterdam 8
Lappeenranta 8
London 8
Montreal 8
Orem 8
Zurich 8
Atlanta 7
Cardiff 7
City of London 7
Dallas 7
Kingston 7
Philadelphia 7
Bari 6
Florence 6
Guayaquil 6
Jakarta 6
Nairobi 6
Riyadh 6
Washington 6
Brooklyn 5
Can Tho 5
Johannesburg 5
Phoenix 5
Amman 4
Berlin 4
Campinas 4
Denver 4
Dhaka 4
Houston 4
Memphis 4
Palermo 4
Paris 4
Pasadena 4
Santiago 4
Basra 3
Belgrade 3
Biên Hòa 3
Bologna 3
Brasília 3
Catania 3
Caxias do Sul 3
Changsha 3
Charlotte 3
Delhi 3
Des Moines 3
Detroit 3
Istanbul 3
Jeddah 3
Las Vegas 3
Lisbon 3
Madrid 3
Melbourne 3
Nashville 3
Nuremberg 3
Phủ Lý 3
Porto Alegre 3
Quito 3
San Francisco 3
San José 3
Seattle 3
Sumaré 3
Sydney 3
Tashkent 3
Thái Bình 3
Adana 2
Totale 17.847
Salva come PNG Salva come JPEG
Nome #
Bloodstream infections in patients living with HIV in the modern cART era 218
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 212
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 208
Delineating the application of ultrasound in detecting synovial abnormalities of subtalar joint in juvenile idiopathic arthritis 206
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 203
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 201
Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology 198
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 197
The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 193
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 184
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 178
The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 178
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 178
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 173
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis 172
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 169
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 169
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis 168
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 166
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. 164
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 158
Vascular factors predict polyneuropathy in a non-diabetic elderly population 158
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 156
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 156
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy 156
Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients 155
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 154
Non-invasive mitochondrial DNA quantification on day 3 predicts blastocyst development: a prospective, blinded, multi-centric study 154
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 153
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 152
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 151
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas 151
The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 150
Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. 147
The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 147
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 147
Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study 146
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 146
The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 145
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 144
Classification criteria for autoinflammatory recurrent fevers 144
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. 143
A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD 141
Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome 141
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 140
The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 140
The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 140
The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
The Hindi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Afrikaans version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 138
The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 137
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data 137
The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 136
The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 135
The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 134
The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 133
The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 133
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 133
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 133
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 132
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. 131
The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 131
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 129
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 129
A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis 129
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 128
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS 127
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 127
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 126
The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 125
The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 124
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients 124
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 123
Revised upper limb module for spinal muscular atrophy: 12 month changes 121
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 120
Coronary in-stent restenosis: Assessment with CT coronary angiography 119
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 119
The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 119
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 118
The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 117
Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease 117
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 115
Aortic annulus area assessment by multidetector computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation: A comparison with transthoracic and transesophageal echocardiography 114
A data-driven model of disability progression in progressive multiple sclerosis 113
null 113
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 112
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF) 112
The Egyptian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 110
Totale 14.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.465
article - articoli 71.761
book - libri 0
conference - conferenze 508
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 196
Totale 144.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 0 0 0 0 0 0 196
2021/20221.493 95 44 83 121 38 148 54 309 148 173 62 218
2022/20231.661 148 157 24 157 222 269 20 132 297 49 154 32
2023/20241.019 41 122 37 117 73 142 92 57 70 63 81 124
2024/20253.342 98 247 127 229 494 428 355 456 124 151 270 363
2025/20265.985 686 192 489 374 747 489 849 281 526 642 514 196
Totale 20.460